NR1H4 and infectious otitis media: We previously identified that feeding a cholestyramine-supplemented diet to AOM-treated mice reduced FXR-mediated signaling in neurons and improved neurological outcomes (McMillin et al., 2016a) however, this pathway could not adequately account for the increased neuroinflammation observed during HE.